# INPEFA

NDC: 70183-221
Generic name: sotagliflozin
Labeler / Manufacturer: Lexicon Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20230526

FDA application: NDA216203

## Active ingredients

- SOTAGLIFLOZIN: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70183-221"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70183-221
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a46614e-05f6-421a-b6f4-d6f8760d643a